Antigen-Induced Immunomodulation in the Pathogenesis of Atherosclerosis
Figure 1
Inflammatory basis of atherosclerotic
plaque formation. Led
by inflammatory signals derived from the damaged endothelium, monocytes and
lymphocytes migrate into the vessel wall. Monocytes differentiate into
macrophages that recognise and phagocytiose oxidised LDL particles. The protein
component of the LDL particle is processed and presented in the form of
peptides by macrophages (also by dendritic cells) to T-lymphocytes in the
context of the major histocompatibility complex class II (MHC-II). Other self
or foreign antigens that may gain access to the vascular wall can also trigger
similar mechanisms. It is believed that most of these lymphocytes differentiate
in situ, under the influence of
the specific antigen stimulation, into effector T-cells, but this has yet to be
demonstrated. Upon activation, both macrophages and lymphocytes release a range
of proinflammatory molecules including chemokines which stimulate the migration
of smooth muscle cells (SMCs) from the media. SMCs contribute to foam cell
and fibrous cap formation. This process is facilitated by cytokines such as
IFN and TNFα secreted by proatherogenic Th1 cells and also IL-12 secreted by
macrophages and foam cells. Eventually foam cells die by apoptosis in situ leaving nondegradable
cholesterol crystals that form the lipid core of the plaque.